Achieve Life Sciences, Inc. Restructuring Charges
Achieve Life Sciences, Inc. (ACHV) reported Restructuring Charges of $431.00 thousand for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2016-05-12
- Achieve Life Sciences, Inc. restructuring charges for the quarter ending 2016-03-31 was $431.00K.
- Achieve Life Sciences, Inc. restructuring charges for fiscal 2012 was -$1.66M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 12 month |
|---|---|---|
| 2016-03-31 | $431.00K 10-Q · filed 2016-05-12 | |
| 2012-12-31 | -$1.66M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |